Skip to main content

Waters to Purchase NuGenesis Technologies for $43M

NEW YORK, Jan. 28 (GenomeWeb News) – Milford, Mass.-based Waters Corp. today announced that it is buying the privately-held software company, NuGenesis Technologies of Westborough, Mass, for approximately $43 million, in a transaction that is expected to close in the first quarter, subject to certain conditions, the company said in a statement.

NuGenesis, which was founded in 1996 and was formerly known as Mantra Software, develops and markets the NuGenesis Scientific Data Management Systems product line.

Waters said that it will blend NuGenesis’s platform, in combination with products and technologies from Creon Lab Control, acquired in July, to seek a leadership position in the scientific information management arena.

Major investors in the NuGenesis include: TA Associates (Boston), Highland Capital Partners (Lexington, Mass.), BancBoston Ventures, Brentwood Venture Capital (Menlo Park, Calif.), and St. Paul Venture Capital (Eden Prairie, Minn.). NuGenesis took in a $26 million round of venture-capital finance in May 2000.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.